Concepedia

Eliezer Shochat

ES

Statistics

Publications

14

Citations

873

H-Index

14

Active since

1998

Affiliations

Roche (Switzerland)(Current)

Weizmann Institute of Science

Tel Aviv University

Inserm

Institut Gustave Roussy

Eliezer Shochat is an author at Roche (Switzerland) specializing in medicine, immunology, and oncology.

Top concepts

Publications per year

1998–2016

14

Publications

14

The growth law of primary breast cancer as inferred from mammography screening trials data

Deborah R. Hart, Eliezer Shochat, Zvia Agur · British Journal of Cancer · 1998 · 165 citations · Full text

, , +12

First-in-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-in-Class Dual MEK/RAF Inhibitor in Patients with Solid Tumors

Maria Martinez‐García, Udai Banerji, Joan Albanell et al. · Clinical Cancer Research · 2012 · 151 citations

Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa, Óscar Puig, Bruno Daniele et al. · Journal of Hepatology · 2016 · 123 citations

, , +9

Mathematical Model of BCG Immunotherapy in Superficial Bladder Cancer

Svetlana Bunimovich‐Mendrazitsky, Eliezer Shochat, Lewi Stone · Bulletin of Mathematical Biology · 2007 · 92 citations

, , +4

Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors

Suzanne Leijen, Mark R. Middleton, Patricia Tresca et al. · Clinical Cancer Research · 2012 · 71 citations

1–5 of 14